Welcome to our dedicated page for Gentherm SEC filings (Ticker: THRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gentherm Inc (NASDAQ: THRM) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. Gentherm uses these filings to report on its financial condition, operating results and material events related to its thermal management and pneumatic comfort technologies businesses in the automotive and medical sectors.
Key documents for THRM include annual reports on Form 10-K and quarterly reports on Form 10-Q, where Gentherm presents product revenues from its Automotive and Medical segments, discusses automotive climate and comfort solutions, and describes risk factors such as macroeconomic conditions in the automotive industry, trade policies, supply chain constraints, foreign currency exposure and regulatory oversight of its patient temperature management business.
Gentherm also files current reports on Form 8-K to announce material events, such as the public release of quarterly results and updates to financial guidance. Recent 8-K filings reference earnings news releases and conference calls used to discuss product revenues, Adjusted EBITDA, liquidity, net leverage and other metrics the company tracks.
On this page, Stock Titan enhances Gentherm’s filings with AI-powered summaries that explain the key points of lengthy documents, helping readers understand segment performance, non-GAAP measures and important risk disclosures without reading every page. Real-time updates from EDGAR mean new THRM filings, including 10-K, 10-Q and 8-K reports, appear promptly.
Investors can also use the filings page to locate information that Gentherm references in its news releases, such as detailed risk factor discussions in its Form 10-K and subsequent filings. Together, the original documents and AI-generated highlights offer a structured view of how Gentherm reports its automotive and medical operations to regulators and the market.
Gentherm plans to combine with Modine’s Performance Technologies business in a Reverse Morris Trust transaction valued at approximately $1.0 billion. Modine is expected to receive a $210 million cash distribution and about 21 million new Gentherm shares, with post-deal ownership around 60% Gentherm shareholders and 40% Modine shareholders.
The combined company is projected to have $2.6 billion in pro forma revenue, a post-synergy adjusted EBITDA margin of 13% and net leverage of roughly 1.0x, with closing targeted for the fourth quarter of 2026. Gentherm also raised its preliminary 2025 product revenue range to $1.49–$1.50 billion, while trimming adjusted EBITDA to $173–$177 million, implying an 11.6%–11.8% margin.
Gentherm Incorporated filed an 8-K announcing a planned combination of Gentherm with the Performance Technologies business of Modine Manufacturing Co. (the “Proposed Transaction”). The Modine business will be separated into a new company, SpinCo, which will then be involved in the transaction with Gentherm.
Gentherm issued a press release and investor presentation about the Proposed Transaction, furnished as Exhibits 99.1 and 99.2, and held a conference call and webcast on January 29, 2026. The companies plan to file a Form S-4 with a proxy statement/prospectus for Gentherm shareholders and a Form 10 for SpinCo. The filing includes extensive forward-looking statement cautions and lists regulatory approvals, shareholder approval, tax treatment, integration challenges, and potential litigation as key risks that could affect completion and expected benefits of the deal.
Gentherm (THRM) reported Q3 results for the period ended September 30, 2025. Product revenue was $386,870, with gross margin of $95,148 and operating income of $23,858. Net income was $14,949, or diluted EPS of $0.49. Interest expense, net, was $3,313, and the effective tax rate was 28.4%.
For the nine months, operating cash flow reached $87,820, ending cash and cash equivalents were $154,250. Total debt was $189,109, primarily the U.S. dollar revolving credit facility at $189,000; $307,938 remained available for additional borrowings. Letters of credit outstanding were $3,062.
The company advanced multi‑region restructuring to optimize its manufacturing footprint. The 2025 Manufacturing Footprint Plan anticipates cash restructuring costs of $3,000–$4,000 for severance and $1,000 of other transition costs, plus $1,000–$2,000 of capital expenditures. The 2025 EMEA Plan expects $4,000–$6,000 for severance and $2,000–$3,000 of other costs, plus $1,000–$2,000 of capital expenditures. The 2025 Asia Plan expects $2,000–$3,000 for severance and $1,000 of other costs, plus $2,000–$3,000 of capital expenditures. As of October 17, 2025, shares outstanding were 30,525,148; year‑to‑date repurchases totaled $10,015, with $110,103 remaining under the authorization.
Gentherm Incorporated reported that it publicly announced its third‑quarter 2025 financial results and updated its full‑year 2025 guidance. The company furnished a press release as Exhibit 99.1.
The company will host a conference call on October 23, 2025 at 8:00 a.m. Eastern Time to discuss results and guidance. Supplemental materials are available on the Events page of the Investors section at www.gentherm.com. The information furnished under Items 2.02 and 7.01 is not deemed filed under the Exchange Act.
Gentherm Inc. insider Sundaram Vishnu, SVP and Chief Technology Officer, reported a sale of 1,242 shares of common stock on 09/26/2025 at a price of $34.81 per share. After the transaction he beneficially owned 21,905 shares. The Form 4 was signed by an authorized representative on 09/30/2025.
Nicholas Breisacher, identified as a Director and Chief Accounting Officer of Gentherm Inc. (THRM), reported a transaction on 08/29/2025 selling 38 shares of common stock at $36.85 per share. Following the sale, he beneficially owns 4,223 shares held directly. The filing was signed by a power of attorney.
Barbara J. Runyon, SVP and CHRO of Gentherm Inc. (THRM), reported an insider sale. On 08/21/2025 she sold 3,348 shares of Gentherm common stock at a weighted average price of $34.82 per share, with sale prices ranging from $34.781 to $34.87. After the sale she beneficially owned 31,316 shares, reported as direct ownership. The Form 4 was signed by a power of attorney on 08/25/2025.
This Form 144 notifies a proposed sale of 3,348 shares of Gentherm Inc. common stock (NASDAQ: THRM) with an aggregate market value of $116,438.1108/21/2025. The shares were acquired on 03/07/2022 as a stock grant from Barbara Runyon (6,005 shares acquired on that date) and payment/consideration is recorded as a stock grant. The filer reports no securities sold in the past three months. Several standard form fields (filer CIK/CCC/contact and the name of the person for whose account the securities are to be sold) are blank in the provided content. The filing includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.